Olsen RK, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B et al (2007) ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency
In such scenarios, tools like the Revised Face, Legs, Activity, Cry, Consolability (r-FLACC) scale can be particularly useful
Small molecule GLP-1 receptor agonists, ideally orally bioavailable, could be a fascinating new approach for activating GLP-1 receptor signaling while mimicking the natural route of GLP-1 absorption and distribution and eliminating the need for injections [20]
When semaglutide binds to these receptors during early treatment phases, some patients report feeling warmer or experiencing increased sweating, especially at night or during physical activity
they are research observations in laboratory models